MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.ajkd.2012.03.015

Медицинская библиотека · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2012

Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.

Kucirka Lauren M, Peters Thomas G, Segev Dorry L

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Only 29% of deceased donor kidney recipients with hepatitis C virus (HCV) receive HCV-positive (HCV+) kidneys. These kidneys are discarded 2.5 times more often than their HCV-negative (HCV-) counterparts, possibly due to the sense that an HCV+ kidney may adversely affect recipient liver function. The goals of this study were to characterize liver disease in HCV+ kidney recipients and compare rates of liver-related outcomes by kidney donor HCV status.

STUDY

DESIGN

Observational cohort study.

SETTING &

PARTICIPANTS

6,250 patients with HCV who had a kidney transplant in 1995-2008 as captured in the United Network for Organ Sharing (UNOS) database. Liver-related outcomes were assessed by cross-linking with the liver waitlist and transplant data sets.

PREDICTOR: HCV status of transplanted kidney.

OUTCOMES: Joining the liver waitlist, receiving a liver transplant, death.

MEASUREMENTS: Time to event.

RESULTS

Only 63 (1%) of HCV+ kidney recipients eventually joined the liver waitlist during the 13-year study period. Those who received HCV+ kidneys had a 2.6-fold higher hazard of joining the liver list (P < 0.001); however, the absolute difference in rate of listing between recipients of HCV- and HCV+ kidneys was <2%. This is consistent with findings of only 2% lower patient survival at 3 years in HCV+ patients receiving HCV+ versus HCV- kidneys.

LIMITATIONS: We lacked data for HCV viral load and genotype of both HCV+ recipients and transplanted HCV+ kidneys.

CONCLUSIONS

Because transplant with an HCV+ kidney may reduce waiting-time by more than a year for an HCV+ patient and there is a high risk of kidney waitlist mortality, a 2% increased rate of adverse liver outcomes and 2% increased rate of death at 3 years should not universally preclude the use of HCV+ kidneys when the intended recipient is also HCV+.

Для цитирования: Kucirka Lauren M, Peters Thomas G, Segev Dorry L. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2012. DOI: 10.1053/j.ajkd.2012.03.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.